Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |